Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4

US Patent 11433086 · Granted Sep 6, 2022

Estimated economic value: $621,000

Assignee

Inventors

View full patent text on Google Patents →